Veatch Robert M
Kennedy Institute of Ethics, Georgetown University, Washington DC, USA.
J Med Philos. 2007 Mar-Apr;32(2):167-83. doi: 10.1080/03605310701255776.
It is commonly believed in research ethics that some form of equipoise is a necessary condition for justifying randomized clinical trials, that without it clinicians are violating the moral duty to do what is best for the patient. Recent criticisms have shown how complex the concept of equipoise is, but often retain the commitment to some form of equipoise for randomization to be justified. This article rejects that claim. It first asks for what one should be equally poised (scientific or clinical equipoise), then asks who should be equally poised (scientist, clinician, or subject), and finally asks why any of these players need be equally poised between treatment options. The article argues that only the subject's evaluation of the options is morally relevant and that even the subject need not be equally poised or indifferent between the options in order to volunteer for randomization. All that is needed is adequately informed, free, and unexploited consent. It concludes equipoise is irrelevant.
在研究伦理中,人们普遍认为某种形式的 equipoise 是证明随机临床试验合理性的必要条件,即没有它,临床医生就违背了为患者做最有利之事的道德责任。近期的批评揭示了 equipoise 概念是多么复杂,但往往仍坚持认为需要某种形式的 equipoise 才能使随机化合理。本文反对这一观点。它首先询问人们应该在什么方面保持平衡(科学或临床 equipoise),接着询问谁应该保持平衡(科学家、临床医生还是受试者),最后询问为什么这些参与者中的任何一方需要在治疗方案之间保持平衡。本文认为只有受试者对这些方案的评估在道德上是相关的,而且即使受试者也不必在方案之间保持平衡或无差异才能自愿参与随机化。所需要的只是充分知情、自由且未被利用的同意。它得出结论,equipoise 无关紧要。